DIA
Drug Information Association Logo

PHARMA INDUSTRY INCENTIVE SYSTEMS

Track:
Innovation in R&D Models

Day & Time:
March 27, 4:00PM - 5:30PM (Central European Standard Time)

Session Number:
1408

Room Number:
Room NO

Type:
Session

Title:
PHARMA INDUSTRY INCENTIVE SYSTEMS

Chair(s):
Peter Hongaard Andersen, DrMed, DrSc
Senior Vice President
H. Lundbeck A/S, Denmark

Salah-Dine Chibout, PhD
Head of Exploratory Development Europe. Global Head Investigative Toxicology
Novartis Pharma AG, Switzerland

Description:
Science brings us towards a world of personalized medicines. However, current incentive systems punish companies targeting specific patient groups enriched with responders and thus prevent translation of science to medical innovation.

Presentation(s) & Speaker(s):
Creating a Future for the Pharma Industry through Innovation Ecosystems
Wim Vanhaverbeke
Hasselt University, Belgium

How Close are We to “Targeted” Medicines?
Chas Bountra
Structural Genomics Consortium, United Kingdom

Are Current Incentive Systems Facilitating the Introduction of Targeted Medicines?
Peter Hongaard Andersen, DrMed, DrSc
Senior Vice President
H. Lundbeck A/S, Denmark